Mylan (MYL) Sued by Shareholder Over EpiPen Payments
Tweet
Share
E-mail
Get Alerts MYL Hot Sheet
Join SI Premium – FREE
Mylan (NASDAQ: MYL) shares are on watch after an investor sued the company over allegations that it made misstatements on payments made to government health-insurance programs with respect to its EpiPen product, according to Bloomberg.
The lawsuit was filed in Manhattan court Tuesday.
Shares of Mylan are down around 1 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Horizon Bancorp faces $3M jury verdict in auto repossession case
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
- Chemours reaches $450M settlement over PFAS pollution at four sites
Create E-mail Alert Related Categories
Insiders' Blog, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
